Search company, investor...

Predict your next investment

Corporation
cordlife.com

Investments

1

Partners & Customers

2

About Cordlife Group

Cordlife Group is a consumer healthcare company catering to the mother and child segment, providing cord blood and umbilical cord lining banking services.

Headquarters Location

#06-01/09 A'Posh Bizhub 1 Yishun Industrial Street 1

768160,

Singapore

+65 6238 0808

Want to inform investors similar to Cordlife Group about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Cordlife Group News

Cord Blood Processing & Storage Equipment Market Research Report by Type, Treatment Type, Application, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Dec 27, 2022

Report by Type, Treatment Type, Application, End-user, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06337773/?utm_source=GNW 68% to reach USD 594.43 million by 2027. Market Statistics: The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period. Market Segmentation & Coverage: This research report categorizes the Cord Blood Processing & Storage Equipment to forecast the revenues and analyze the trends in each of the following sub-markets: Based on Type, the market was studied across Automated and Semi-Automated. Based on Treatment Type, the market was studied across Anti-Rejection Drugs/Immunosuppressants, Antiviral Drugs, Chemotherapy Drugs, Corticosteroids, IImmunoglobulins, Targeted Therapy, and Vaccines. Based on Application, the market was studied across Anemia, Autism, Cerebral Palsy, Diabetes, Leukemia, and Thalassemia. Based on End-user, the market was studied across Hospitals, Research Institutes, and Specialty Clinics. Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market. Cumulative Impact of 2022 Russia Ukraine Conflict: We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cord Blood Processing & Storage Equipment market considering the current update on the conflict and its global response. Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period. FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cord Blood Processing & Storage Equipment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape. Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits. Competitive Scenario: The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service. Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cord Blood Processing & Storage Equipment Market, including Americord Registry LLC, CBR Systems, Inc., CORDLIFE GROUP LIMITED, Cordlife India, Cryo-Cell International, Inc., FamiCord Group, Global Cord Blood Corporation, LifeCell International Pvt. Ltd., Singapore Cord Blood Bank Limited, StemCyte Inc., ViaCord, LLC, and Vita 34 AG. The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments The report answers questions such as: 1. What is the market size and forecast of the Global Cord Blood Processing & Storage Equipment Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cord Blood Processing & Storage Equipment Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cord Blood Processing & Storage Equipment Market? 4. What is the competitive strategic window for opportunities in the Global Cord Blood Processing & Storage Equipment Market? 5. What are the technology trends and regulatory frameworks in the Global Cord Blood Processing & Storage Equipment Market? 6. What is the market share of the leading vendors in the Global Cord Blood Processing & Storage Equipment Market? 7. What modes and strategic moves are considered suitable for entering the Global Cord Blood Processing & Storage Equipment Market?

Cordlife Group Investments

1 Investments

Cordlife Group has made 1 investments. Their latest investment was in CellResearch Corporation as part of their Corporate Minority on February 2, 2016.

CBI Logo

Cordlife Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/2/2016

Corporate Minority

CellResearch Corporation

$5.9M

Yes

1

Date

2/2/2016

Round

Corporate Minority

Company

CellResearch Corporation

Amount

$5.9M

New?

Yes

Co-Investors

Sources

1

Cordlife Group Acquisitions

1 Acquisition

Cordlife Group acquired 1 company. Their latest acquisition was HealthBaby - Hong Kong on January 04, 2018.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

1/4/2018

$99M

Acquired Unit

1

Date

1/4/2018

Investment Stage

Companies

Valuation

$99M

Total Funding

Note

Acquired Unit

Sources

1

Cordlife Group Partners & Customers

2 Partners and customers

Cordlife Group has 2 strategic partners and customers. Cordlife Group recently partnered with ThermoGenesis (acquired by Cesca Therapeutics) on June 6, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

6/26/2019

Partner

United States

2

7/23/2014

Partner

China

Subscribe to see more

Subscribe to see more

10

Date

6/26/2019

7/23/2014

Type

Partner

Partner

Business Partner

Country

United States

China

News Snippet

Subscribe to see more

Subscribe to see more

Sources

2

10

Cordlife Group Team

5 Team Members

Cordlife Group has 5 team members, including , .

Name

Work History

Title

Status

Michael Rosenzweig

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Michael Rosenzweig

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.